UPDATED Opioid Laws FAQ's
Changes made to Start Talking Form, MAPS Registration & Use and Acute Pain
LARA and DHHS worked on updating the FAQs regarding the Opioid Laws. You can find these updated FAQs online at www.michigan.gov/mimapsinfo
- Frequently Asked Questions Opioid Laws
The changes that were made to the FAQs are as follows:
PA 246 of 2017 – Start Talking Form:
Q-5a, Page 6 – Added the word “or unlicensed” to be consistent with what the delegation provision of the Public Health Code, MCL 333.16215.
Q-5b and 6b, Page 6 – Added: “Please note that not all prescribers as defined under the Public Health Code have the ability to delegate under the delegation provision of MCL 333.16215.”
Q-7a, Page 6 – Added: “Continuation of the established previous therapy does not require a new form.”
Q-7c, Page 6 – Added: “If the prescriber starts to treat the patient with a new opioid the form would need to be signed and saved in the patient file.
Q-7d, Page 6 – Added: “When changing the dosage of the same opioid prescription, in a course of treatment, the form would not need to be signed and saved in the patient file.”
Q-8a, Page 7 – Added: “For example, administration of the opioid for inpatient stay within, but not limited to, a hospital, freestanding surgical outpatient facility, skilled nursing facility, hospice, homes for aged, etc.”
Q-8c and 8d, Page 7 – Added: Reference about the Public Health Code definition of “Administer” and definition of “Dispense”.
PA 248 of 2017 – MAPS Registration & Use:
Q-2b, Page 9 – Added: “This law does not apply to a prescriber who orders a schedule 2-5 controlled substance for inpatient administration.”
Q-2c, Page 9 – Added: Clarified when a licensed veterinarian has to review MAPS.
Q-2d and 2e, Page 9 – Added: Reference about the Public Health Code definition of “Administer” and definition of “Dispense”.
Q-3a and 3b, Pages 9-10 – Added: New question regarding issuing multiple prescriptions and “do not fill until date”.
Q-4a, Page 10 – Added: In addition to the website for MAPS, added reference about training videos also can be found on this site.
Q-9b, Page 11 – Added: “Please note it is important that the prescriber reviews the MAPS report prior to prescribing or dispensing a schedule 2-5 controlled substance that exceeds a 3-day supply.
Q-20b , Page 13 - Added: “Please note, prescribers and dispensers are not required to save a copy of the MAPS report, whether electronic or hard copy, as the software system that MAPS operates on also has audit trail capabilities.”
PA 251 of 2017 – Acute Pain:
Q-1c, Page 14 – Added: “This law does not apply to chronic pain.”
Q-3a, Page 15 – Added: Question about whether law applies to veterinarians, which it does not.